A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists semaglutide and liraglutide, ...

The discovery could lead to a new treatment for millions of people with obesity and type 2 diabetes who do not respond well ...

"While GLP-1-based therapies have revolutionized patient care for obesity and type 2 diabetes, safely harnessing energy expenditure and controlling appetite without nausea remain two Holy Grails in ...

WEDNESDAY, Nov. 13, 2024 (HealthDay News) -- The blockbuster GLP-1 drug semaglutide ( Ozempic, Wegovy) could curb drinking ...

Early studies show a drug can effectively 'switch on' particular cells within the nervous system that play an important role ...

Hims & Hers (HIMS) is launching a new GLP-1 tracker in its efforts to fight back against the FDA’s decision to end compounded ...

Whether these departments get the money will be decided later, but the Scene listened in on requests from the Department of Health, the Department of Disability and Aging, the Division of TennCare and ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...

Carter also said that the longer diabetics wait to get their eyes checked, the more at risk they are for potential eye-sight ...

Substance use disorders (SUDs) are a major public health concern, with opioid use disorder (OUD) and alcohol use disorder ...